DDB2 and breast carcinoma: Collectively, our findings indicate DDB2 as a critical mediator of chemoresistance through its role in facilitating DNA repair and suppressing apoptosis following chemotherapy in breast cancer, lung cancer, liver cancer, and cholangiocarcinoma.